( February 5, 2025, 10:34 AM EST) -- PHILADELPHIA — The manufacturers of diabetes and diet drugs that consumers allege cause gastrointestinal and other injuries moved to dismiss certain claims from a master long-form complaint against the drug manufacturers in the multidistrict litigation that they allege “are extraneous to the core issues in the litigation, inadequately pleaded, or plainly foreclosed.”...